SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-021237
Filing Date
2022-08-04
Accepted
2022-08-04 07:20:09
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 667852
2 ex31-1.htm EX-31.1 12147
3 ex31-2.htm EX-31.2 12199
4 ex32-1.htm EX-32.1 4684
5 ex32-2.htm EX-32.2 4515
  Complete submission text file 0001493152-22-021237.txt   3783603

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xtnt-20220630.xsd EX-101.SCH 31343
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xtnt-20220630_cal.xml EX-101.CAL 60975
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xtnt-20220630_def.xml EX-101.DEF 87767
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xtnt-20220630_lab.xml EX-101.LAB 269961
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xtnt-20220630_pre.xml EX-101.PRE 207576
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 533180
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 221134667
SIC: 2836 Biological Products, (No Diagnostic Substances)